Dr Thomas Exner

Dr Thomas Exner

Job Title: 
Chief Scientific Officer (CSO)

Dr Thomas Exner is responsible for the scientific planning, execution and supervision of different commercial project in the area of data management and integrated testing strategy development for risk/safety assessment of chemicals, drugs and nano materials. Additionally, he is coordinating the H2020 e-infrastructure project OpenRiskNet, is work package leader in the ACEnano and NanoCommons project, leads the creation of a knowledge infrastructure in the EU-ToxRisk project as well as functions as principal investigator in the Marie Skłodowska-Curie Innovative Training Network in3.

He studied chemistry and did his PhD in physical chemistry at the Technische Universität Darmstadt. After a postdoctoral stay at the University of Saskatchewan, Canada, he was appointed Assistant Professor at the University of Konstanz in 2003. In April 2012, he moved to the Institute of Pharmacy at the University of Tübingen and continued his research in close co-operation with the experimental and theoretical groups at the Institute until early 2015, when he moved to Douglas Connect.

Dr. Exner is the author and co-author of more than 50 articles in peer reviewed international journals and several other scientific contributions.

Latest Tweets

Edelweiss Connect (2 weeks ago)
RT @EU_ToxRisk: The EU-ToxRisk NAM-based Testing Commercialization Platform presented during the @EU_ToxRisk Open Symposium, Feb 12, 2020 i…
Edelweiss Connect (2 weeks ago)
RT @Biopredic_Intl: We are glad to announce the launch of the new HepaRG #logo !! Worldwide recognized and quite unique human hepatic stem…
Edelweiss Connect (3 weeks ago)
The SafeDESIgn imaging-based toxicity reporter platform for chemical safety assessment #SaferWorldbyDesign… https://t.co/7xeN1d6w6t
Edelweiss Connect (5 weeks ago)
The latest #OpenTox webinar focused on #AOPs current trends and developments, presented by Tatyana Doktorova https://t.co/ZKj5PivfiN
Edelweiss Connect (5 weeks ago)
RT @barryhardy: Tatyana Doktorova will discuss current trends and developments in Adverse Outcome Pathways as exemplified by case studies (…

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland

USA office

  • Address: Edelweiss Connect Inc
    Research Triangle Park NC
    800 Park Offices Dr
    Durham, NC 27709
    USA